| 1. |
- Heijl, Caroline, et al.
(författare)
-
Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials.
- 2011
-
Ingår i: Annals of the Rheumatic Diseases. - : BMJ. - 1468-2060 .- 0003-4967. ; 70, s. 1415-1421
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVES: /st> Because standard immunosuppressive treatment for antineutrophil cytoplasm antibody-associated vasculitis (AAV) (granulomatosis with polyangiitis (Wegener's) (GPA) and microscopic polyangiitis (MPA)) has been associated with a significant risk of developing cancer, the cancer incidence of treated AAV patients was assessed. METHODS: /st> This analysis concerned 535 patients with newly diagnosed AAV from 15 countries who had been enrolled between 1995 and 2002 in four European clinical trials. Over the period 2004-7, study participants' follow-up events were updated, including cancers diagnosed. Age, sex and area-standardised incidence ratios (SIR) and their 95% CI were calculated by linkage to five national cancer databases. RESULTS: /st> During the 2650 person-years' observation period, 50 cancers were diagnosed in 46 patients. SIR (95% CI) were 1.58 (1.17 to 2.08) for cancers at all sites, 1.30 (0.90 to 1.80) for cancers at all sites excluding non-melanoma skin cancer (NMSC), 2.41 (0.66 to 6.17) for bladder cancer, 3.23 (0.39 to 11.65) for leukaemia, 1.11 (0.03 to 6.19) for lymphoma and 2.78 (1.56 to 4.59) for NMSC. Subgroup SIR for cancers at all sites were 1.92 (1.31 to 2.71) for GPA and 1.20 (0.71 to 1.89) for MPA. CONCLUSIONS: /st> Cancer rates for AAV patients treated with conventional immunosuppressive therapy exceeded those expected for the general population. This cancer excess was largely driven by an increased incidence of NMSC. The smaller cancer risk magnitude in this cohort, compared with previous studies, might reflect less extensive use of cyclophosphamide in current treatment protocols. Longer follow-up data are warranted to appraise the risk of developing cancers later during the course of AAV.
|
|
| 2. |
- Fadel, Hani T, 1979, et al.
(författare)
-
Caries risk and periodontitis in patients with coronary artery disease.
- 2011
-
Ingår i: Journal of periodontology. - : Wiley. - 1943-3670 .- 0022-3492. ; 82:9, s. 1295-303
-
Tidskriftsartikel (refereegranskat)abstract
- ACKGROUND: There is considerable variation in studies on the oral health of patients with coronary artery disease (CAD). The aims of this investigation are to study the caries risk profile using the Cariogram computer program and the periodontal disease severity in patients with CAD. METHODS: A total of 127 participants (54 test and 73 control) were included. Participants were asked about their general health and daily habits. Clinical examinations, radiographs, and salivary sampling were performed. Cariologic data were entered into the computer program for risk-profile illustration. The onset of CAD conditions was also documented. RESULTS: Compared with controls, participants with CAD consumed less sugar, used fluoride toothpaste less frequently, and had significantly less favorable periodontal parameters (P <0.005). Generally, differences in cariologic parameters between the two groups were not significant. Significantly more participants with CAD exhibited low salivary-secretion rates than controls. The actual chance (percentage) of avoiding new cavities according to the Cariogram was low in the test and control groups (31% and 40%, respectively; P <0.05). Only gingival recession was correlated with the onset of CAD. CONCLUSIONS: Test and control groups had a relatively high caries risk. More severe periodontal disease was observed in participants with CAD.
|
|
| 3. |
- Köhler, Elof, 1980, et al.
(författare)
-
High temperature energy harvester for wireless sensors
- 2014
-
Ingår i: Smart Materials and Structures. - : IOP Publishing. - 0964-1726 .- 1361-665X. ; 23:9, s. Art. no. 095042-
-
Tidskriftsartikel (refereegranskat)abstract
- Implementing energy harvesters and wireless sensors in jet engines will simplify development and decrease costs by reducing the need for cables. Such a device could include a small thermoelectric generator placed in the cooling channels of the jet engine where the temperature is between 500-900 degrees C. This paper covers the synthesis of suitable thermoelectric materials, design of module and proof of concept tests of a thermoelectric module. The materials and other design variables were chosen based on an analytic model and numerical analysis. The module was optimized for 600-800 degrees C with the thermoelectric materials n-type Ba8Ga16Ge30 and p-type La-doped Yb14MnSb11, both with among the highest reported figure-of-merit values, zT, for bulk materials in this region. The materials were synthesized and their structures confirmed by x-ray diffraction. Proof of concept modules containing only two thermoelectric legs were built and tested at high temperatures and under high temperature gradients. The modules were designed to survive an ambient temperature gradient of up to 200 degrees C. The first measurements at low temperature showed that the thermoelectric legs could withstand a temperature gradient of 123 degrees C and still be functional. The high temperature measurement with 800 degrees C on the hot side showed that the module remained functional at this temperature.
|
|
| 4. |
- Rossetti, L, et al.
(författare)
-
Focusing on glaucoma progression and the clinical importance of progression rate measurement: a review.
- 2010
-
Ingår i: Eye (London, England). - : Springer Science and Business Media LLC. - 1476-5454 .- 0950-222X. ; 24 Suppl 1, s. 1-7
-
Tidskriftsartikel (refereegranskat)abstract
- PURPOSE: This review aims to provide guidance in managing glaucoma patients more effectively. It focuses on the importance of detecting progression and measuring its rate within the management of primary open-angle glaucoma today. Recent findings strongly indicate that continued monitoring of visual fields (VFs) and reassessment of target intraocular pressures (IOPs) depending on VF progression rates are mandatory in the management of glaucoma. METHODS: Data on glaucoma progression from older as well as most recent literature findings are summarized in this article. In addition, the article elaborates on the scientific content from a series of lectures given by experts in the field during several international symposia on 'rate of progression' in 2008. RESULTS: This review summarizes key findings on the natural history of glaucoma and known factors for disease progression. It highlights the visual function changes observed as glaucoma progresses and discusses disease impact on patients' quality of life. Findings support the need to obtain information on rate of progression and its importance for clinical management. Practical ways to measure rate of progression are given by new software options to help measure major parameters. Finally, on the basis of a patient's individual rate of progression therapeutic options are assessed, such as maximum medical therapy with fixed combinations. CONCLUSIONS: Estimating a patient's individual rate of VF progression by using newly developed analyses will be helpful to forecast the potential future development of the glaucoma. An individualized treatment approach then requires that in patients in whom the risk of becoming visually impaired or blind during their lifetime is higher, a more intensive medical IOP-lowering therapy such as fixed combinations can be considered as treatment option.
|
|
